Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 1, 1989
Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancerP A Reece, I Stafford, M Davy, et al.Clinical Pharmacology and Therapeutics|April 1, 1996
Inhibition of tacrine oral clearance by cimetidineS T Forgue, P A Reece, A J Sedman, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
A model for ultrafilterable plasma platinum disposition in patients treated with cisplatinP A Reece, I Stafford, J Russell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicityP A Reece, I Stafford, J Russell, et al.Therapeutic Drug Monitoring|January 1, 1986
Direct measurement of salicylphenolic glucuronide in human urineD M Imhoff, P A Reece, E Dimitriadis, et al.Journal of Pharmaceutical Sciences|February 1, 1985
Synthesis, formulation, and clinical pharmacological evaluation of hydralazine pyruvic acid hydrazone in two healthy volunteersP A Reece, I Stafford, R H Prager, et al.Cancer Research|June 1, 1987
Pharmacokinetics of trimetrexate administered by five-day continuous infusion to patients with advanced cancerP A Reece, R G Morris, J F Bishop, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
The effect of food on oral melphalan absorptionP A Reece, D Kotasek, R G Morris, et al.Journal of Clinical Pharmacology|September 3, 1999
Gabapentin does not affect antipyrine clearanceE Allen, L M Tsanaclis, S J Wroe, et al.Journal of Clinical Pharmacology|November 1, 1994
Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humansP A Reece, A J Sedman, S Rose, et al.Pageof 4